Overview

A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The aim of the study is to compare efficacy and toxicity of melphalan and prednisone versus meplhalan, prednisone and Thalidomide in elderly patients with multiple myeloma or patients with multiple myeloma but not eligible for high dose treatment with stem cells support.

Phase:

Phase 2

Details

Lead Sponsor:

Gruppo Italiano Studio Linfomi

Treatments:

Melphalan
Prednisone
Thalidomide